Zevra Therapeutics (ZVRA) Goodwill (2023 - 2026)

Zevra Therapeutics (ZVRA) has 4 years of Goodwill data on file, last reported at $4.7 million in Q1 2026.

• Quarterly Goodwill changed 0.0% year-over-year to $4.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $4.7 million (changed 0.0% YoY) and the FY2025 annual result came in at $4.7 million, changed 0.02% from the prior year.
• Goodwill was little changed at $4.7 million in Q1 2026, from $4.7 million in the prior quarter.
• In the past five years, Goodwill ranged from a high of $4.7 million in Q4 2023 to a low of $4.7 million in Q2 2024.
• A 4-year average of $4.7 million and a median of $4.7 million in 2023 frame the typical range for Goodwill.
• The widest YoY moves for Goodwill: up 0.02% in 2025, down 0.02% in 2025.
• Tracing ZVRA's Goodwill over 4 years: stood at $4.7 million in 2023, then changed by 0.0% to $4.7 million in 2024, then retreated by 0.02% to $4.7 million in 2025, then increased by 0.02% to $4.7 million in 2026.
• The last three Goodwill figures came in at $4.7 million (Q1 2026), $4.7 million (Q4 2025), and $4.7 million (Q3 2025), per Business Quant data.